Investing in Innovation
Research at the UMass Cancer Center is leading to the development of new anti-cancer drugs and therapeutic strategies for treating a variety of malignancies including breast, ovarian, colon, leukemia, lung, prostate cancer and more.
Partner with UMass Chan Medical School and gain early access to a diversity of innovations available for licensing, world-renowned research expertise, start-up opportunities, investment opportunities, and opportunities to support our activities.
BRIDGE Innovation & Business Development serves as the hub of all commercialization activities at UMass Chan Medical School. It facilitates intellectual property protection, business opportunity development, technology licensing, and new-enterprise creation.